NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.860
+0.010 (0.35%)
Oct 29, 2024, 4:00 PM EDT - Market closed
NeuroBo Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -25.9 | -12.47 | -13.97 | -15.28 | -29.68 | -21.31 | |
Depreciation & Amortization | 0.02 | 0.01 | 0.02 | 0.05 | 0.05 | 0.02 | |
Other Amortization | - | - | 2.19 | - | - | - | |
Loss (Gain) From Sale of Assets | - | - | 0.08 | - | - | - | |
Asset Writedown & Restructuring Costs | - | - | 8.21 | - | 17.34 | 12.15 | |
Stock-Based Compensation | 0.51 | 0.22 | 0.85 | 0.66 | 0.7 | 0.12 | |
Other Operating Activities | 0.24 | -2.95 | -7.93 | 0.02 | 0.02 | 1.24 | |
Change in Accounts Payable | 1.25 | 0.11 | -0.2 | -1.16 | 1.12 | -1.05 | |
Change in Other Net Operating Assets | 3.99 | 4.28 | -0.97 | 0.58 | -0.31 | 1.79 | |
Operating Cash Flow | -19.9 | -10.8 | -11.71 | -15.13 | -10.76 | -7.04 | |
Capital Expenditures | -0.05 | -0.05 | - | -0 | -0 | -0.21 | |
Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | - | |
Cash Acquisitions | - | - | - | -0.58 | 0.07 | -5.84 | |
Investing Cash Flow | -0.05 | -0.05 | 0.01 | -0.59 | 0.07 | -6.06 | |
Issuance of Common Stock | 20 | - | 32.25 | 24.12 | 7.55 | 0 | |
Other Financing Activities | -0.8 | -0.08 | -3.57 | -2.09 | -0.7 | -0.07 | |
Financing Cash Flow | 19.2 | -0.08 | 28.68 | 22.03 | 6.86 | 24.17 | |
Foreign Exchange Rate Adjustments | - | - | - | -0.01 | 0 | 0.01 | |
Net Cash Flow | -0.75 | -10.93 | 16.98 | 6.3 | -3.83 | 11.08 | |
Free Cash Flow | -19.95 | -10.85 | -11.71 | -15.14 | -10.77 | -7.25 | |
Free Cash Flow Per Share | -3.86 | -2.14 | -36.41 | -156.98 | -159.36 | -333.21 | |
Cash Interest Paid | - | - | - | - | - | 0 | |
Levered Free Cash Flow | -10.44 | -15.55 | 4.24 | -10 | -5.77 | -2.58 | |
Unlevered Free Cash Flow | -10.44 | -15.55 | 5.61 | -10 | -5.77 | -2.5 | |
Change in Net Working Capital | -5.67 | 5.8 | -9.68 | 1.14 | -1.23 | -2.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.